GL-0719 clinical trials

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

This study is looking at a new medicine called GL-0719. It will check how safe it is and how the body handles it in healthy people. It will also see if it helps people with a rare blood condition called cold agglutinin disease (CAD).